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Substantial information concerning the
contamination of northern marine food by
organochlorines (OCs) is now available
(Braune et al. 1999; Burkow and Kallenborn
2000; Muir et al. 1999). This family of com-
pounds includes chlorinated pesticides
[dichlorodiphenyltrichloroethane (DDT),
dieldrin, mirex, and toxaphene] and industrial
compounds [hexachlorobenzene (HCB) and
polychlorinated biphenyls (PCBs)]. Several
OCs are chemically stable. They are thus resis-
tant to biodegradation and can accumulate in
adipose tissue of living organisms. This leads
to their biomagnification in the aquatic and
terrestrial food chain, resulting in the highest
levels in top predator species (Braune et al.
1999; Evans et al. 1991; Muir et al. 1999;
Skaare et al. 2000). The manufacture of most
OCs was halted in the 1970s when regulatory
actions were adopted to limit their production
and use. Today, OCs are still released into the
environment due to improper storage and
ongoing use in certain parts of the world.
For cultural and economical reasons,
carnivorous fish and marine mammals con-
stitute an important part of the diet of the
Inuit population of Nunavik (northern
Québec, Canada). Their exposure to bio-
magnified substances, such as OCs, is thus
proportionally high. Several studies have
identiﬁed markedly higher concentrations of
OCs in adult blood, umbilical cord blood,
and breast milk of Nunavik inhabitants com-
pared with those of the southern Québec
population (Ayotte et al. 1997, 2003;
Dewailly et al. 1989, 1993, 1998; Muckle
et al. 1998, 2001; Rhainds et al. 1999).
Exposure to most OCs produces a wide
variety of immunotoxic effects in animals and
humans. OCs that have a chemical structure
similar to 2,3,7,8-tetrachlorodibenzo-p-
dioxin, such as dioxin congeners and coplanar
PCBs, are especially immunotoxic. Alterations
of T-cell subsets, of serum IgA and IgM con-
centrations, of delayed-type hypersensitivity,
and of complement function, have been
documented in primates and humans (Belles-
Isles et al. 2002; Chang et al. 1982; Hoffman
et al. 1986; Lu and Wu 1985; Neubert et al.
1992; Tryphonas et al. 1991a, 1991b). The
development of the immune system in utero
and during infancy is particularly sensitive to
immunotoxic agents. High exposure during
early life could lead to permanent defects in
the immune system and thus decrease resis-
tance to infectious agents (Badesha et al.
1995). 
The high incidence of acute infectious dis-
eases in infants and children from Nunavik has
been known for many years (Bruneau et al.
2001; Dufour 1988; Proulx 1988; Thérien
1988). In this context, we hypothesized that
the incidence of infections among Inuit infants
was related in part to the high maternal body
burden of immunotoxic food-chain contami-
nants during pregnancy. In 2000, we pub-
lished a first study on susceptibility to
infection in Inuit infants recruited between
1989 and 1990 (Dewailly et al. 2000). We
found that the risk of acute otitis media and
recurrent otitis media was positively associated
with prenatal exposure to OCs. However,
postnatal exposure was not considered, and
some potential confounding factors could not
be evaluated. To confirm the association
observed, we investigated the association
between exposure to OCs and the incidence
rate of acute infections during the ﬁrst year of
life in a second cohort of 199 Inuit infants
recruited between 1995 and 2001.
Material and Methods
Study population and recruitment. The
Nunavik region is located north of the 55th
parallel in the province of Québec, Canada,
and is composed of 14 isolated villages scat-
tered along the coasts of the Ungava Bay,
the Hudson Strait, and the Hudson Bay
(Figure 1). The targeted participants for this
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The Inuit population of Nunavik (Canada) is exposed to immunotoxic organochlorines (OCs)
mainly through the consumption of fish and marine mammal fat. We investigated the effect of
perinatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene
(DDE) on the incidence of acute infections in Inuit infants. We reviewed the medical charts of a
cohort of 199 Inuit infants during the ﬁrst 12 months of life and evaluated the incidence rates of
upper and lower respiratory tract infections (URTI and LRTIs, respectively), otitis media, and
gastrointestinal (GI) infections. Maternal plasma during delivery and infant plasma at 7 months of
age were sampled and assayed for PCBs and DDE. Compared to rates for infants in the ﬁrst quar-
tile of exposure to PCBs (least exposed), adjusted rate ratios for infants in higher quartiles ranged
between 1.09 and 1.32 for URTIs, 0.99 and 1.39 for otitis, 1.52 and 1.89 for GI infections, and
1.16 and 1.68 for LRTIs during the ﬁrst 6 months of follow-up. For all infections combined, the
rate ratios ranged from 1.17 to 1.27. The effect size was similar for DDE exposure but was lower
for the full 12-month follow-up. Globally, most rate ratios were > 1.0, but few were statistically
signiﬁcant (p < 0.05). No association was found when postnatal exposure was considered. These
results show a possible association between prenatal exposure to OCs and acute infections early in
life in this Inuit population. Key words: cord blood, environmental health, gastrointestinal infec-
tions, human, infant, infections, Inuit, organochlorines, otitis, pesticides, polychlorinated
biphenyls, prenatal exposure, respiratory tract infections. Environ Health Perspect 112:1359–1364
(2004). doi:10.1289/ehp.7255 available via http://dx.doi.org/ [Online 18 August 2004]
Environmental Medicine Articlestudy were Inuit infants born in Puvirnituq,
Inukjuaq, and Kuujjuarapik, the three largest
Inuit communities on the Hudson Bay coast
in Nunavik. The recruitment procedures have
been described elsewhere (Muckle et al. 2001).
Brieﬂy, between November 1995 and March
2001, we attempted to contact every pregnant
woman after their ﬁrst prenatal medical visit
either by phone or by the community radio
(for those without a telephone at home).
Pregnant women were invited to meet with
our research assistant, and women willing to
participate were asked to sign an informed
consent form. The study was part of a larger
study focusing on environmental contaminants
and neurobehavioral development. The study
protocol was reviewed and approved by the
Nunavik Health and Nutrition Committee
and by the ethics committee of Laval
University.
Data collection and biological sampling. In
order to gather biological samples and informa-
tion on confounding variables, we conducted
four interviews: one at midpregnancy (prenatal
interview, median of 21 weeks gestation) and
three with the infant and the mother at 1, 6,
and 11 months postpartum. We collected
information on maternal age, breast-feeding
duration, socioeconomic status of the care-
giver (Hollingshead index), smoking habits
during pregnancy, environmental tobacco
exposure during the ﬁrst year of life, number
of children living with the participant, village
of residence, and day care attendance. Many
other characteristics were also documented for
the neurobehavioral arm of this cohort but
were not included in this study.
We sampled maternal blood at delivery or,
when it was impossible, as soon as possible
after delivery (median, 2 days postpartum). We
also obtained umbilical cord blood at delivery
and infant blood at midfollow-up (median,
7.0 months of age). All blood samples were
immediately centrifuged and frozen at –80°C.
Frozen blood and plasma samples were sent to
the Centre de Toxicologie (Institut National
de Santé Publique du Québec, Québec City,
Canada) every 3–6 months for contaminants
and biochemical analyses. Finally, we exten-
sively reviewed the medical charts of the
mother and the infant for the pregnancy
period and for the infant’s ﬁrst year of life.
Determination of OCs. We determined
the concentrations of p,p´-dichlorodiphenyl-
dichloroethylene (DDE) and 14 PCB con-
geners (International Union of Pure and
Applied Chemistry numbers 28, 52, 99, 101,
105, 118, 128, 138, 153, 156, 170, 180, 183,
and 187) in plasma samples by high-resolu-
tion gas chromatography. OCs were extracted
from plasma with ammonium sulfate:ethanol:
hexane (1:1:3). The extracts were cleaned on
florisil columns, taken to a final volume of
100 µL, and analyzed on an HP-5890 series
II gas chromatograph equipped with dual-
capillary columns and dual Ni-63 electron-
capture detectors (Hewlett-Packard, Palo
Alto, CA, USA). We identiﬁed peaks by their
relative retention times obtained on the two
columns. Quality control procedures were
described previously (Rhainds et al. 1999).
Percent recovery ranged from 89 to 100%,
and the detection limit was approximately
0.02 µg/L for all compounds. Coefﬁcients of
variation (n = 20, different days) ranged from
2.1 to 9.1%. The difference between the con-
centration of reference material and that
found using the analytic method ranged from
10.9 to 3.8%. Because OCs are stored mainly
in body fat, all results for contaminants are
expressed on a lipid basis.
Determination of blood lipids. We meas-
ured total cholesterol, free cholesterol, and tri-
glycerides in plasma samples by standard
enzymatic procedures. Concentrations of
phospholipids were determined according to
the enzymatic method of Takayama et al.
(1977) using a commercial kit (Wako Pure
Chemical Industries, Richmond, VA, USA).
We estimated the concentrations of total
plasma lipids using the formula developed by
Phillips et al. (1989).
Estimation of exposure using plasma con-
centrations. In this population, concentrations
of maternal OCs are highly correlated with
those of cord plasma (R = 0.94 for DDE and
PCB-153). Because of logistic problems, we
were not able to collect cord blood samples for
more than half of the participants. Therefore,
we used the concentration of OCs in maternal
plasma as an estimate of prenatal exposure to
OCs. For six subjects, a cord blood sample
was available but not a maternal blood sample.
For these six subjects, we estimated maternal
concentrations from the cord plasma results
using linear regression. Postnatal exposure was
estimated using plasma concentration of OCs
in infant blood at 7 months of age. The 
concentration of OCs in blood is well corre-
lated with that found in adipose tissues, and it
has been shown that either blood or adipose
tissue concentrations are valid exposure
measurements in epidemiologic studies
(Dewailly et al. 1994).
We used PCB-153 concentration (log-
transformed) as a surrogate measure for the
total PCB burden. PCB-153 is the most
abundant PCB congener. Its concentration is
strongly correlated with all the moderate-to-
heavily chlorinated congeners and with most
chlorinated pesticides (except p,p´-DDT). It
has been shown to be a good marker of expo-
sure to most organochlorines in the Arctic
(Muckle et al. 2001).
Medical chart review and incidence of
infectious diseases. Trained research nurses
used a standardized questionnaire to review
the medical charts of infants for the first
12 months of life. For every diagnosed health
problem, we noted the date of diagnosis and
the duration of hospitalization (if hospitalized).
We also attributed a code corresponding to the
International Classification of Primary Care,
2nd edition (ICPC-2; World Organization of
National Colleges, Academies and Academic
Associations of General Practitioners 1998).
We then formed four groups of infections:
upper respiratory tract infections (URTIs), oti-
tis media, gastrointestinal (GI) infections, and
lower respiratory tract infections (LRTIs). We
also added a ﬁfth group labeled “all infections,”
which included all of the four preceding
groups. Because previous studies on OCs and
infections in children seem to point toward a
greater association between OCs and otitis
media compared with other infectious diseases,
we excluded ear infections from the URTI
category so that otitis and URTIs could be
analyzed independently (Chao et al. 1997;
Dewailly et al. 2000; Weisglas-Kuperus et al.
2000). The URTI category included strepto-
coccal pharyngitis and tonsillitis, acute upper
respiratory tract infection not otherwise speci-
fied (NOS), acute rhinitis, head cold, naso-
pharyngitis, pharyngitis, and coryza. The otitis
category included acute suppurative otitis
media, otitis media NOS, acute tympanitis, oti-
tis media with effusion, serous otitis media, and
glue ear. The LRTI category included acute
bronchitis and bronchiolites, acute lower respi-
ratory infection NOS, chest infection NOS,
laryngotracheobronchitis, tracheobronchitis,
bacterial and viral pneumonia, broncho-
pneumonia, inﬂuenzal pneumonia, and pneu-
monitis. The GI infection category included
GI infection and dysentery with specified
organism, diarrhea or vomiting presumed to be
infective, dysentery NOS, and gastric ﬂu.
For every health problem identified, we
trusted the diagnosis of the attending physician.
Environmental Medicine | Dallaire et al.
1360 VOLUME 112 | NUMBER 14 | October 2004 • Environmental Health Perspectives
Figure 1. Location of Inuit communities in Nunavik
(province of Québec, Canada).When two physicians disagreed, we only
recorded the last diagnosis made. In some Inuit
communities, nurses are trained to identify and
treat benign infections, especially otitis media
and URTIs. When the child was not seen by a
physician, we recorded the diagnosis of the
nurse. We considered two episodes of the same
infection type to be separate when there was at
least 15 days between the two diagnoses and
when it was not speciﬁed in the chart that the
second episode was related to the ﬁrst. When
an episode of URTI led to a LRTI, we only
included the latter in the analysis. We did not
attempt to investigate infectious episodes for
which treatment at the health center was not
sought by the parents. Data on complications
or abnormal events during pregnancy, infant
sex, and birth weight were also gathered from
the medical charts.
Statistical analyses. We assigned a value of
one-half the detection limit of the analytical
method when a compound was not detected in
a sample. OC concentrations had log-normal
distributions and were log-transformed in all
analyses. Therefore, results for contaminants
are presented as geometric means. The correla-
tion between contaminant concentrations was
evaluated using Pearson’s method on log-
transformed values. To evaluate associations
between OC exposure and infection incidence
rates, we used Poisson regression with quartiles
of OC concentration as the main independent
variable, and individual incidence rates as the
dependent variable (both for bivariate and
multivariate analyses). We categorized the expo-
sure using quartiles boundaries, with the ﬁrst
quartile as the group of reference (Table 1).
Regression results are, therefore, an estimate of
the incidence rate ratios (RRs) for infants in the
three highest quartiles of exposure, when
infants in each of these quartiles are compared
to infants in ﬁrst quartile. To test the hypothe-
sis of a dose–response association between inci-
dence rates and OC concentrations (p-value for
trend), we included the contaminant concen-
tration (log-transformed) directly in the model
and treated it as a continuous variable.
We based the selection of potential con-
founding variables on clinical knowledge and
a literature review. Every identiﬁed potential
confounding variable was tested in the model,
but only those inﬂuencing the incidence rate
ratios by > 5% were included in the final
model. The variables initially excluded from
the model were retested one by one in the
ﬁnal model to ensure that their exclusion did
not influence the results. The variables
included in the ﬁnal model were maternal age
at delivery (continuous), season of birth, year
of birth (category), breast-feeding duration
(categories), sex of the infant, socioeconomic
status of the caregiver (continuous), smoking
during pregnancy (yes/no), number of ciga-
rettes smoked per day during pregnancy (con-
tinuous), number of children < 6 years of age
living with the infant (continuous), and village
of residence. The following variables were
excluded from the final model because they
did not significantly affect the association of
interest: day care frequentation (ever/never),
mean hours per week in day care (continu-
ous), maternal omega-3 fatty-acid concentra-
tion in blood (continuous), proportion of
omega-3 highly unsaturated fatty acids (con-
tinuous), number of smokers in the house
where the infant resided (continuous), birth
weight, gestational age, and reviewer of the
medical chart. When postnatal exposure was
investigated, we included in the model the
infant’s age when the blood sample was
drawn. We considered vaccination coverage a
potential confounding factor. Information on
vaccination was gathered through the review
of the medical chart, but information was
missing for many children. Preliminary analy-
ses showed that vaccination coverage was not
related to contaminant burden. We thus
excluded it from the ﬁnal models.
All modeling results are presented for both
the crude model (only exposure categories)
and the adjusted model (exposure categories
and all the confounding variables mentioned
above). Statistical analyses and database
management were conducted using the SAS
system 8.02 (SAS Institute, Cary, NC, USA).
By convention, a p-value < 0.05 was considered
signiﬁcant. 
Results
Recruitment and participation. During the
study period, 417 pregnancies were identiﬁed
in the targeted communities. Of them, we
excluded 47 pregnant women (11.3%) who
had already been enrolled in the study during
a previous pregnancy and 3 women (0.7%)
due to miscarriage, and we were unable to
contact 9 women (2.2%). Of the 358 eligible
women asked to participate, 110 (30.7%)
refused. This refusal rate is comparable with
that of other prospective studies with several
interviews in populations of low socio-
economic status. Of the 248 women willing to
participate, we were unable to review the med-
ical charts of 43 infants for the following rea-
sons: 10 (4.0%) moved to another village,
14 (5.6%) were adopted in another village,
11 (4.4%) because of miscarriage or perinatal
mortality, and 8 (3.2%) because the mother
withdrew from the study. Finally, we excluded
6 (2.4%) participants because no biological
samples were available for exposure analysis. A
total of 199 participants were included in the
ﬁnal analyses.
Population characteristics. Mothers
included in the analysis were mostly from
Puvirnituq (45.4%) and Inukjuaq (39.3%).
The mean age at delivery was 25.2 years, and
most of them smoked during pregnancy
(91.4% reported smoking at least 1 cigarette/
day; mean, 10.6 cigarettes/day). Only 2.6%
of the infants were not exposed to second-
hand smoke during their ﬁrst year of life. The
mean parity was 2.1. There were more males
than females (57.6%), and the mean birth
weight and length were 3,454 g and 50.3 cm,
respectively. Breast-feeding was very com-
mon, and only 12.2% were not breast-fed
(most of them because they were adopted).
Incidence of infections. Incidence propor-
tions and rates for selected infections are shown
in Table 2. Otitis media was the most frequent
infection diagnosed, with a mean of 2.8 episodes
per infant-year, followed by URTIs, with 2.4
episodes per infant-year. During the ﬁrst year of
life, almost all infants had at least one episode of
otitis (96.0%), and 17.1% had ﬁve episodes or
more. LRTIs required hospitalization in 31.4%
of cases. More than half of the infants (56.8%)
were hospitalized at least once during their ﬁrst
year of life.
Contaminant burden in plasma. Table 1
shows the concentration of contaminants in
maternal and infant plasma. The geometric
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Table 1. Contaminant concentrations in plasma (µg/kg lipid-based).
Percent Geometric mean Quartile boundaries
Contaminant detected (95% CI) Range 1st 2nd 3rd 4th
Maternal plasma (n = 199)
ΣPCBs NA 308 (279–340) 59.6–1,951 < 190 190–296 296–500 > 500
PCB-153 100 102 (91.4–113) 14.6–709 < 57.6 57.6–98.4 98.4–170 > 170
DDE 100 294 (267–324) 54.3–2,269 < 183 183–281 281–472 > 472
Infant plasma (n = 172)
ΣPCBs NA 259 (218–307) 26.9–3,801 < 99.0 99.0 –283 283–609 > 609
PCB-153 96.5 76.1 (62.4–92.9) ND–1,441 < 28.0 28.0–95.3 95.3–199 > 199
DDE 100 256 ( 214–307) 15.6–4,386 < 100 100–355 355–618 > 618
Abbreviations: CI, conﬁdence interval; NA, not applicable; ND, not detected.mean concentration of the sum of the 14 PCB
congeners (ΣPCBs) in maternal plasma was
308 µg/kg (range, 60–1,951 µg/kg). The con-
centration of the ΣPCBs was highly correlated
with that of PCB-153 in maternal plasma
(r = 0.99). The correlation between cord
plasma and maternal plasma was also very high,
both for the ΣPCBs and for PCB-153 (r = 0.95
and 0.94, respectively). The geometric mean
concentration for DDE in maternal plasma was
294 µg/kg (range, 54–2,269 µg/kg). The corre-
lation between cord and maternal plasma sam-
ples for DDE was also very strong (r = 0.94).
Mean concentrations of PCBs and DDE were
lower in infant plasma compared to those in
maternal plasma.
Prenatal exposure to PCB-153 and infec-
tions. The association between prenatal expo-
sure to PCB-153 and incidence of infections is
shown in Table 3. In preliminary analyses we
found that the associations between OCs and
incidence rates were somewhat stronger dur-
ing the first 6 months of life. Although this
study was designed for a 12-month follow-up,
we also present the results for the first
6 months of life. Regarding infections during
the first 6 months of life and prenatal expo-
sure to PCBs, we observed statistically signiﬁ-
cant associations only for LRTIs (3rd quartile;
RR = 1.54 and 1.68 for the unadjusted and
adjusted models, respectively). Although not
statistically significant, almost all other RRs
were above the unity. When the four types of
infections were combined, the relative rates
ranged from 1.19 to 1.20 in the unadjusted
model and from 1.17 to 1.27 in the adjusted
model. The trend was statistically signiﬁcant
in the adjusted model (p = 0.04).
Compared to the ﬁrst 6 months of life, the
effect size was lower when the ﬁrst 12 months
of life were considered, and only GI infections
still pointed toward a positive association. The
association was signiﬁcant for the 3rd quartile
in the adjusted model only (RR = 1.59).
Globally, rate ratios were similar in the unad-
justed and adjusted models.
Prenatal exposure to DDE and infections.
The association between incidence of infec-
tions and prenatal exposure to DDE (Table 4)
was similar to that observed for exposure to
PCB-153. For the first 6 months of life, we
detected significant associations with otitis
(RR = 1.63, 3rd quartile) and LRTIs (RR =
1.52, 2nd quartile) in the unadjusted model,
and with URTIs (RR = 1.56, 2nd quartile)
and otitis (RR = 1.83, 3rd quartile) in the
adjusted model. The trend was signiﬁcant for
otitis in the unadjusted model (p = 0.04) and
borderline significant in adjusted model
(p = 0.07). When the four types of infections
were combined, we observed signiﬁcant asso-
ciations for the 2nd quartile (RR = 1.49) in
the unadjusted model, and for the 2nd
(RR = 1.38) and 3rd (RR = 1.33) quartiles in
the adjusted model. As observed for PCB
exposure, almost all RRs were above the unity.
When considering the ﬁrst 12 months of
life, we observed signiﬁcant associations for GI
infections (RR = 1.49, 2nd quartile) in the
unadjusted model, and for URTIs (RR = 1.34,
2nd quartile) and GI infections (RR = 1.59,
2nd quartile) in the adjusted model. For all
infections combined, the association reached
statistical signiﬁcance only for the 2nd quartile
in the unadjusted model (RR = 1.17).
Postnatal exposure to OCs and infections.
We used OC concentrations in infant plasma
to evaluate the effect of postnatal exposure on
incidence of infections (sampling done at a
median age of 7.0 months). We observed no
association between postnatal exposure and
the incidence of infections (data not shown).
The only signiﬁcant association was for PCBs
(12-month follow-up, 2nd quartile, RR = 1.19)
in the unadjusted model, but the statistical sig-
nificance was lost when adjustment for con-
founding was done.
Effects of exposure to OCs on hospitaliza-
tion rate. We found no signiﬁcant association
between prenatal or postnatal exposure and
incidence rate of hospitalization for LRTIs
(data not shown). However, statistical power
was poor because of the limited number of
admissions.
Discussion
Accidental and occupational exposure to PCBs
has already been associated with increased sus-
ceptibility to infections in infants. Rogan et al.
(1988) observed that mothers who were
exposed to PCBs through the consumption of
contaminated rice oil (Yu-Cheng) reported a
higher rate of bronchitis in their children than
did control mothers. After examination by
two otolaryngologists, the same children were
also shown to have a higher prevalence of
middle ear diseases than matched controls
(Chao et al. 1997). In Japan, Hara (1985)
noted that infants born to women who had
handled PCBs in a capacitor factory had a
higher incidence of colds and GI complaints.
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Table 2. Incidence proportion and mean infection incidence rate for all participants (n = 199).
Mean incidence Percentage of
(episodes per episodes requiring Percentage of participants who had at least
Infection person × year) hospitalization 1 episode 3 episodes 5 episodes
URTIs 2.4 ± 1.7 1.3 90.0 42.7 12.6
Otitis media 2.8 ± 1.7 0 96.0 52.8 17.1
GI infections 1.0 ± 1.1 3.4 58.8 10.6 0.5
LRTIs 1.7 ± 1.7 31.4 73.4 26.6 5.5
Table 3. Incidence RR of each PCB-153 quartile of prenatal exposure compared to the ﬁrst quartile.
Unadjusted (n = 199) Adjusted (n = 177)a
Incidence RR (95% CI)b Incidence RR (95% CI)b
2nd quartile 3rd quartile 4th quartile p-Value 2nd quartile 3rd quartile 4th quartile p-Value for
Infection type (n = 50) (n = 50) (n = 50) for trendc (n = 40) (n = 46) (n = 45) trendc
6-Month follow-up
URTIs 1.08 (0.76–1.55) 0.98 (0.68–1.41) 1.19 (0.84–1.68) 0.69 1.08 (0.69–1.67) 1.08 (0.71–1.65) 1.32 (0.87–2.00) 0.22
Otitis media 1.33 (0.85–2.07) 1.15 (0.73–1.82) 1.30 (0.83–2.02) 0.17 1.11 (0.65–1.89) 0.99 (0.59–1.66) 1.39 (0.82–2.35) 0.17
GI infections 1.63 (0.80–3.34) 1.31 (0.62–2.76) 1.55 (0.75–3.20) 0.33 1.89 (0.78–4.56) 1.52 (0.65–3.54) 1.54 (0.66–3.60) 0.38
LRTIs 1.12 (0.71–1.76) 1.54 (1.01–2.35)* 1.01 (0.63–1.61) 0.61 1.16 (0.65–2.09) 1.68 (1.00–2.81)* 1.18 (0.68–2.04) 0.38
All infectionsd 1.19 (0.95–1.50) 1.18 (0.94–1.48) 1.19 (0.95–1.50) 0.14 1.17 (0.88–1.55) 1.19 (0.92–1.54) 1.27 (0.98–1.66) 0.04*
12-Month follow-up
URTIs 0.93 (0.72–1.20) 0.87 (0.67–1.13) 1.12 (0.88–1.43) 0.81 0.99 (0.71–1.36) 0.96 (0.71–1.29) 1.23 (0.92–1.65) 0.29
Otitis media 1.05 (0.83–1.32) 0.97 (0.76–1.22) 0.94 (0.75–1.20) 0.89 1.02 (0.77–1.35) 0.89 (0.68–1.17) 0.97 (0.73–1.28) 0.89
GI infections 1.27 (0.86–1.88) 1.22 (0.82–1.82) 1.05 (0.69–1.58) 0.81 1.53 (0.94–2.49) 1.59 (1.01–2.49)* 1.26 (0.78–2.04) 0.29
LRTIs 0.88 (0.65–1.19) 1.08 (0.81–1.45) 0.96 (0.71–1.29) 0.48 0.86 (0.57–1.28) 1.10 (0.78–1.55) 1.03 (0.72–1.48) 0.36
All infectionsd 1.00 (0.87–1.15) 0.99 (0.86–1.14) 1.01 (0.88–1.16) 0.67 1.02 (0.86–1.21) 1.01 (0.86–1.19) 1.08 (0.92–1.28) 0.24
CI, conﬁdence interval.
aModel included mother’s age, season of birth, year of birth, breast-feeding duration, sex, socioeconomic status of the caregiver, tobacco use during pregnancy, village of residence, and
number of children living with the participant. bIncidence RR when the given quartile was compared to the ﬁrst quartile of exposure (Poisson regression). cp-Values for trends were calcu-
lated by Poisson regression in which the contaminant concentration (lipid-based) was entered as a continuous variable (log-transformed). dOnly infections with a mean incidence
> 1.0 episode/year/infant were included; see details in “Materials and Methods”). *p < 0.05.However, evidence of an effect of environ-
mental OC exposure on susceptibility to infec-
tion in children is scarce and inconsistent. To
our knowledge, the ﬁrst study addressing this
question was conducted in the Great Lakes
area (Smith 1984); the author observed that
ﬁsh consumption during pregnancy (a proxy of
PCB exposure) was positively associated with
colds, earaches, and ﬂu symptoms in infants.
Rogan et al. (1987) followed 900 families in
North Carolina (USA) between 1978 and
1982. They reviewed children’s medical charts
and did not find any evidence of harmful
effects of PCBs or DDE during the ﬁrst year of
life. In the Netherlands, Weisglas-Kuperus
et al. (1995) observed no association between
PCBs and the number of episodes of rhinitis,
bronchitis, tonsillitis, and otitis during the ﬁrst
18 months of life. However, in the same group
of children at 42 months of age, current PCB
burden was associated with a higher prevalence
of recurrent middle ear infections and chicken
pox (Weisglas-Kuperus et al. 2000). Karmaus
et al. (2001) also observed a higher risk of otitis
media, but the association was only present
with the combined exposure to DDE and
PCBs. Finally, our laboratory previously
reported that exposed Inuit infants had a
higher risk of acute otitis media during the ﬁrst
year of life (third tertile of exposure compared
to the ﬁrst) (Dewailly et al. 2000). The associa-
tion was signiﬁcant with exposure to DDE and
HCB but remained above the unity for PCBs,
dieldrin, and mirex. 
In this study, we showed that prenatal
exposure to some environmental OC contami-
nants was possibly associated with a higher inci-
dence rate of infections during the first
6 months of life. Although the associations were
not always statistically significant because of
limited statistical power, infants in the highest
quartiles of PCB and DDE exposure had sys-
tematically more episodes of infections than
their counterparts in the ﬁrst quartile of expo-
sure. This was mostly observed during the ﬁrst
6 months of life, as the effect size was lower
when infections during the ﬁrst 12 months of
life were considered. Postnatal exposure to OCs
was not associated with infection incidence.
In the literature, middle ear infections are
the most consistently reported infections
associated with prenatal exposure to OCs. In
our study, the strongest dose–response rela-
tionship was seen with ear infections.
However, it is likely that insults of OCs on
the developing immune system would result
in the increase of incidence of many different
types of acute infections and not only ear
infections. Consistent with that assumption,
our results showed a higher incidence rate for
the four most frequent infections in infants
in the higher exposure groups, and the rate
ratios were similar to that observed for otitis.
Furthermore, when these four types of infec-
tions were combined, the association was
more stable and the magnitude of the dose–
response relationship was increased, com-
pared with that of the four types of infection
taken separately.
We also observed that the effect of pre-
natal exposure was mostly present during the
first few months of life and that this effect
seemed to vanish after 6 months of life.
Furthermore, we found no effect of postnatal
exposure to OCs with infections. It has
already been suggested that the immune sys-
tem is vulnerable to immunotoxic com-
pounds during its development and that high
maternal burden during pregnancy and lacta-
tion could lead to permanent defects on the
infant’s immune system (Badesha et al. 1995;
Barnett et al. 1987). Our results support the
hypothesis of a stronger effect during early
infancy, but we were unable to clearly iden-
tify any harmful effect persisting after the age
of 6 months. After a few months of life,
cumulative environmental influences on the
immune system may begin to play a larger
role, thus increasing the variability of
responses to infections. Furthermore, contri-
butions of the OC exposure via breast milk,
entangled with the beneﬁcial effect of breast-
feeding on infections, might have masked the
effect. This could explain in part the discrep-
ancies in results of other studies on OCs and
infections because the age of children during
disease and exposure assessment varied con-
siderably between studies. Further studies are
needed to clarify the time period during
which environmental exposure to OCs has a
detrimental effect on children health.
In this population, plasma concentrations
of many environmentally persistent OCs are
strongly correlated (Muckle et al. 2001).
Muckle et al. (2001) also showed that concen-
trations in cord plasma, maternal plasma, and
breast milk samples are also strongly correlated.
With such exposure, it is therefore not possible
to attribute the effect observed to one speciﬁc
OC compound, nor are we able to unravel the
specific contribution of PCB-153 exposure
from DDE exposure. Furthermore, our data
did not allow us to determine whether the
association between DDE and infections was
due to an immune modulation property of
DDE, to co-linearity with PCB-153, or both.
We used a review of the medical charts to
evaluate disease frequency. There is only one
health center in each of the three Inuit com-
munities included in this study, and partici-
pants almost always go to that heath center
when they seek medical attention; copies of
consultations performed elsewhere are rou-
tinely requested to complete medical charts.
We are therefore confident that we have
reviewed a majority of the medical consulta-
tions sought by the participants. Nevertheless,
we did not attempt to verify every diagnosis,
nor did we try to inquire about infections for
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Table 4. Incidence RR of each DDE quartile of prenatal exposure compared to the ﬁrst quartile
Unadjusted (n = 199) Adjusted (n = 177)a
Incidence RR (95% CI)b Incidence RR (95% CI)b
2nd quartile 3rd quartile 4th quartile p-Value 2nd quartile 3rd quartile 4th quartile p-Value for
Infection type (n = 50) (n = 50) (n = 50) for trendc (n = 40) (n = 46) (n = 45) trendc
6-Month follow-up
URTIs 1.50 (1.05–2.13) 1.06 (0.72–1.55) 1.19 (0.82–1.73) 0.91 1.56 (1.05–2.33)* 1.15 (0.75–1.75) 1.40 (0.90–2.16) 0.24
Otitis media 1.27 (0.79–2.05) 1.63 (1.04–2.57)* 1.50 (0.95–2.38) 0.04* 1.03 (0.59–1.77) 1.83 (1.09–3.07)* 1.55 (0.90–2.68) 0.07
GI infections 2.16 (1.02–4.55)* 1.76 (0.81–3.82) 1.67 (0.76–3.64) 0.34 1.91 (0.84–4.35) 1.66 (0.69–3.97) 1.35 (0.54–3.42) 0.58
LRTIs 1.52 (1.00–2.32)* 1.01 (0.64–1.59) 1.01 (0.64–1.59) 0.75 1.40 (0.86–2.29) 1.22 (0.72–2.05) 0.96 (0.55–1.66) 0.89
All infectionsd 1.49 (1.19–1.87)* 1.23 (0.97–1.55) 1.25 (0.99–1.57) 0.22 1.38 (1.07–1.78)* 1.33 (1.03–1.73)* 1.27 (0.96–1.67) 0.11
12-Month follow-up
URTIs 1.27 (0.98– 1.63) 1.03 (0.79– 1.34) 1.11 (0.85–1.44) 0.85 1.34 (1.00–1.78)* 1.09 (0.81–1.47) 1.30 (0.96–1.78) 0.27
Otitis media 1.00 (0.79–1.27) 1.12 (0.89–1.42) 1.08 (0.85–1.36) 0.36 0.89 (0.68–1.17) 1.08 (0.83–1.41) 1.02 (0.76–1.35) 0.72
GI infections 1.49 (1.00–2.23)* 1.30 (0.86–1.96) 1.20 (0.79–1.82) 0.98 1.59 (1.03–2.47)* 1.27 (0.81–2.00) 1.43 (0.87–2.34) 0.59
LRTIs 1.15 (0.85–1.55) 0.96 (0.70–1.30) 1.05 (0.78–1.42) 0.89 1.07 (0.75–1.51) 0.98 (0.69–1.40) 1.00 (0.69–1.45) 0.99
All infectionsd 1.17 (1.02–1.35)* 1.08 (0.93–1.24) 1.09 (0.95–1.26) 0.59 1.13 (0.97–1.33) 1.08 (0.92–1.26) 1.13 (0.95–1.34) 0.38
CI, conﬁdence interval.
aModel included mother’s age, season of birth, year of birth, breast-feeding duration, sex, socioeconomic status of the caregiver, tobacco use during pregnancy, village of residence,
and number of children living with the participant. bIncidence RR when the given quartile was compared to the ﬁrst quartile of exposure (Poisson regression). cp-Values for trends were
calculated by Poisson regression in which the contaminant concentration (lipid-based) was entered as a continuous variable (log-transformed). dOnly infections with a mean incidence
> 1.0 episode/year/infant were included; see details in “Materials and Methods”). *p < 0.05.which medical attention was not sought by
the parents. Furthermore, we did not find a
suitable proxy for the propensity to go to the
clinic when symptoms were present (health
services are free of charge in Canada). Our
results are therefore likely to be an underesti-
mation of the true incidence. This under-
estimation is expected to be present for
benign infection, but is unlikely to be signiﬁ-
cant for LRTIs. This underestimation may be
associated with traditional lifestyle, and thus
with OC exposure, but the direction of the
bias is unknown. However, if such a bias was
present, we could assume that it would have
persisted beyond 6 months of age. RRs for
the 12-month follow-up are close to unity;
therefore, the bias seems to have little effect
on our results.
Because of the relatively small number of
subjects involved (n = 199), our results must
be regarded with caution. Many factors can
greatly inﬂuence the rate of acute infections.
We have assessed several potential confound-
ing factors, but unknown factors might still
be present. Specifically, we cannot rule out
the possibility that the infants in the lowest
exposure group (ﬁrst quartile) had better gen-
eral health due to an unknown cause or sim-
ply due to chance. This would have resulted
in RRs above the unity for the three highest
quartiles of exposure without any dose–
response association, which is similar to what
we observed. This should be kept in mind in
interpreting our results.
The high rate of infectious episodes in
young Inuit children has been observed in
northern Canada, the United States (Alaska),
and Greenland (Banerji et al. 2001; Holman
et al. 2001; Koch et al. 2002; Proulx 1988;
Wainwright 1996). Many cultural, environ-
mental, and economical factors contribute to
this situation. Our study population is no
exception, with a mean of almost nine 
infection-related medical consultations per
infant during the ﬁrst 12 months of life. In the
context of such a high rate of infections, rate
ratios of around 1.25, like the ones observed
in this study, could have a tremendous impact
on the public health of this population. This is
the second study identifying a possible associa-
tion between acute infections and prenatal
exposure to OCs in Nunavik. However, the
relatively small number of subjects raises the
possibility of an association that could be due
to chance. To further clarify the potential con-
tribution of persisting contaminants in the
high infection rate of these children, we are
currently conducting another study in which a
third cohort of Inuit children from the same
population is being followed during the ﬁrst
5 years of life. Other studies are also needed
to identify which immune mechanisms are
involved and to better understand the role of
maternal passive immunity in these infants.
In the meantime, awareness and precautions
regarding the selection of marine food items
before and during pregnancies are warranted.
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